Literature DB >> 26914322

Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.

Kimberley D Lucas, Valorie Eckert, Czarina N Behrends, Charlotte Wheeler, Robin J MacGowan, Janet C Mohle-Boetani.   

Abstract

Early diagnosis of human immunodeficiency virus (HIV) infection and initiation of antiretroviral treatment (ART) improves health outcomes and prevents HIV transmission. Before 2010, HIV testing was available to inmates in the California state prison system upon request. In 2010, the California Correctional Health Care Services (CCHCS) integrated HIV opt-out screening into the health assessment for inmates entering California state prisons. Under this system, a medical care provider informs the inmate that an HIV test is routinely done, along with screening for sexually transmitted, communicable, and vaccine-preventable diseases, unless the inmate specifically declines the test. During 2012-2013, CCHCS, the California Department of Public Health, and CDC evaluated HIV screening, rates of new diagnoses, linkage to and retention in care, ART response, and post-release linkage to care among California prison inmates. All prison inmates are processed through one of eight specialized reception center facilities, where they undergo a comprehensive evaluation of their medical needs, mental health, and custody requirements for placement in one of 35 state prisons. Among 17,436 inmates who entered a reception center during April-September 2012, 77% were screened for HIV infection; 135 (1%) tested positive, including 10 (0.1%) with newly diagnosed infections. Among the 135 HIV-positive patient-inmates, 134 (99%) were linked to care within 90 days of diagnosis, including 122 (91%) who initiated ART. Among 83 who initiated ART and remained incarcerated through July 2013, 81 (98%) continued ART; 71 (88%) achieved viral suppression (<200 HIV RNA copies/mL). Thirty-nine patient-inmates were released on ART; 12 of 14 who were linked to care within 30 days of release were virally suppressed at that time. Only one of nine persons with a viral load test conducted between 91 days and 1 year post-release had viral suppression. Although high rates of viral suppression were achieved in prison, continuity of care in the community remains a challenge. An infrastructure for post-release linkage to care is needed to help ensure sustained HIV disease control.

Entities:  

Mesh:

Year:  2016        PMID: 26914322     DOI: 10.15585/mmwr.mm6507a3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  10 in total

1.  Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers.

Authors:  Carolina de la Flor; Esmaeil Porsa; Ank E Nijhawan
Journal:  Public Health Rep       Date:  2017-10-18       Impact factor: 2.792

Review 2.  Improving Post-Release Care Engagement for People Living with HIV Involved in the Criminal Justice System: A Systematic Review.

Authors:  Matthew Moher; Margaret Erickson; Paleah Black; Morgan Price; Christopher Fraser; Wendy V Norman; Silvia Guillemi; Neora Pick; Ruth Elwood Martin
Journal:  AIDS Behav       Date:  2021-10-27

3.  Opt-out Testing Pilot for Sexually Transmitted Infections Among Immigrant Detainees at 2 Immigration and Customs Enforcement Health Service Corps-Staffed Detention Facilities, 2018.

Authors:  Edith Lederman; Andria Blackwell; Gina Tomkus; Misty Rios; Brent Stephen; Ada Rivera; Philip Farabaugh
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

4.  An application of agent-based modeling to explore the impact of decreasing incarceration rates and increasing drug treatment access on sero-discordant partnerships among people who inject drugs.

Authors:  Sabriya L Linton; Don C Des Jarlais; Joseph T Ornstein; Matt Kasman; Ross Hammond; Behzad Kianian; Justin C Smith; Mary E Wolfe; Zev Ross; Danielle German; Colin Flynn; Henry F Raymond; R Monina Klevens; Emma Spencer; John-Mark Schacht; Teresa Finlayson; Gabriela Paz-Bailey; Cyprian Wejnert; Hannah L F Cooper
Journal:  Int J Drug Policy       Date:  2021-03-31

5.  Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health.

Authors:  Meghan D Morris; Brandon Brown; Scott A Allen
Journal:  Int J Prison Health       Date:  2017-09-11

6.  A systematic review and meta-analyses on initiation, adherence and outcomes of antiretroviral therapy in incarcerated people.

Authors:  Terefe G Fuge; George Tsourtos; Emma R Miller
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

Review 7.  Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review.

Authors:  Seth Francis-Graham; Nnenna Adaniya Ekeke; Corey Andrew Nelson; Tin Yan Lee; Sulaima El Haj; Tim Rhodes; Cecilia Vindrola; Tim Colbourn; William Rosenberg
Journal:  BMC Health Serv Res       Date:  2019-03-08       Impact factor: 2.655

8.  A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review.

Authors:  Joseph Cox; Cassidy Gutner; Nadine Kronfli; Anna Lawson; Michele Robbins; Lisette Nientker; Amrita Ostawal; Tristan Barber; Davide Croce; David Hardy; Heiko Jessen; Christine Katlama; Josep Mallolas; Giuliano Rizzardini; Keith Alcorn; Michael Wohlfeiler; Eric Le Fevre
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

9.  Factors affecting optimal adherence to antiretroviral therapy and viral suppression amongst HIV-infected prisoners in South Ethiopia: a comparative cross-sectional study.

Authors:  Terefe Gone Fuge; George Tsourtos; Emma R Miller
Journal:  AIDS Res Ther       Date:  2022-01-29       Impact factor: 2.250

10.  Various structural factors influenced early antiretroviral therapy initiation amongst HIV infected prisoners: a qualitative exploration in South Ethiopia.

Authors:  Terefe Gone Fuge; George Tsourtos; Emma R Miller
Journal:  BMC Public Health       Date:  2021-07-28       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.